Home » Topics » BioWorld Science

BioWorld Science
RSS

New EAAT3 inhibitors divulged by Roche

May 10, 2018

Lundbeck updates pipeline progress of first quarter 2018

May 10, 2018

Syndax Pharmaceuticals describes preclinical activity of Menin/MLL1 inhibitor VTP-50469

May 10, 2018

Lodo Therapeutics and Genentech enter multi-target strategic collaboration

May 10, 2018

Escient Pharmaceuticals launches to advance first-in-class GPCR-targeted drugs

May 10, 2018

Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice

May 10, 2018

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Provention Bio acquires rights to teplizumab and MGD-010 from MacroGenics

May 10, 2018

IGEM Therapeutics awarded grant from Innovate UK

May 10, 2018

AcelRx Pharmaceuticals resubmits Dsuvia NDA in U.S.

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...